Canada markets closed

Royalty Pharma plc (RPRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
28.00-0.11 (-0.39%)
At close: 04:00PM EDT
28.00 0.00 (0.00%)
After hours: 05:32PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 12.51B
Enterprise Value 17.41B
Trailing P/E 11.07
Forward P/E 8.24
PEG Ratio (5 yr expected) 1.17
Price/Sales (ttm)7.17
Price/Book (mrq)1.92
Enterprise Value/Revenue 7.39
Enterprise Value/EBITDA 9.22

Trading Information

Stock Price History

Beta (5Y Monthly) 0.45
52-Week Change 3-20.75%
S&P500 52-Week Change 322.36%
52 Week High 335.76
52 Week Low 325.92
50-Day Moving Average 329.61
200-Day Moving Average 328.79

Share Statistics

Avg Vol (3 month) 32.79M
Avg Vol (10 day) 32.55M
Shares Outstanding 5446.69M
Implied Shares Outstanding 6597.44M
Float 8384.42M
% Held by Insiders 13.79%
% Held by Institutions 171.61%
Shares Short (Apr 15, 2024) 414.15M
Short Ratio (Apr 15, 2024) 45.83
Short % of Float (Apr 15, 2024) 43.31%
Short % of Shares Outstanding (Apr 15, 2024) 43.17%
Shares Short (prior month Mar 15, 2024) 412.65M

Dividends & Splits

Forward Annual Dividend Rate 40.84
Forward Annual Dividend Yield 43.00%
Trailing Annual Dividend Rate 30.80
Trailing Annual Dividend Yield 32.85%
5 Year Average Dividend Yield 4N/A
Payout Ratio 431.62%
Dividend Date 3Jun 14, 2024
Ex-Dividend Date 4May 16, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 48.20%
Operating Margin (ttm)102.82%

Management Effectiveness

Return on Assets (ttm)5.62%
Return on Equity (ttm)17.34%

Income Statement

Revenue (ttm)2.35B
Revenue Per Share (ttm)5.26
Quarterly Revenue Growth (yoy)5.40%
Gross Profit (ttm)N/A
EBITDA 1.5B
Net Income Avi to Common (ttm)1.13B
Diluted EPS (ttm)2.53
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)495.31M
Total Cash Per Share (mrq)1.11
Total Debt (mrq)6.14B
Total Debt/Equity (mrq)60.84%
Current Ratio (mrq)7.90
Book Value Per Share (mrq)14.61

Cash Flow Statement

Operating Cash Flow (ttm)2.99B
Levered Free Cash Flow (ttm)-1.25B